Search details
1.
Validation of the RSClin risk calculator in the National Cancer Data Base.
Cancer
; 130(8): 1210-1220, 2024 Apr 15.
Article
in English
| MEDLINE | ID: mdl-38146744
2.
Racial differences in familiarity, interest, and use of integrative medicine among patients with breast cancer.
Breast Cancer Res Treat
; 2024 May 15.
Article
in English
| MEDLINE | ID: mdl-38748087
3.
Racial/Ethnic Disparities in Telemedicine Utilization and Satisfaction Among Breast Cancer Patients During the COVID-19 Pandemic: A Mixed-Methods Analysis.
Telemed J E Health
; 30(3): 651-663, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-37676974
4.
Molecular profiling of a real-world breast cancer cohort with genetically inferred ancestries reveals actionable tumor biology differences between European ancestry and African ancestry patient populations.
Breast Cancer Res
; 25(1): 58, 2023 05 25.
Article
in English
| MEDLINE | ID: mdl-37231433
5.
The impact of race and age on response to neoadjuvant therapy and long-term outcomes in Black and White women with early-stage breast cancer.
Breast Cancer Res Treat
; 200(1): 75-83, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-37120458
6.
Clinical trials of immunotherapy in triple-negative breast cancer.
Breast Cancer Res Treat
; 195(1): 1-15, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-35834065
7.
Highly accurate response prediction in high-risk early breast cancer patients using a biophysical simulation platform.
Breast Cancer Res Treat
; 196(1): 57-66, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-36063220
8.
GLORIA: phase III, open-label study of adagloxad simolenin/OBI-821 in patients with high-risk triple-negative breast cancer.
Future Oncol
; 2022 Oct 21.
Article
in English
| MEDLINE | ID: mdl-36268941
9.
Racial disparities in survival outcomes among breast cancer patients by molecular subtypes.
Breast Cancer Res Treat
; 185(3): 841-849, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-33111220
10.
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial).
Breast Cancer Res Treat
; 189(1): 103-110, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-34120223
11.
First-in-human evaluation of the novel mitochondrial complex I inhibitor ASP4132 for treatment of cancer.
Invest New Drugs
; 39(5): 1348-1356, 2021 10.
Article
in English
| MEDLINE | ID: mdl-33830407
12.
TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer.
Breast Cancer Res
; 22(1): 22, 2020 02 18.
Article
in English
| MEDLINE | ID: mdl-32070401
13.
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015.
Breast Cancer Res Treat
; 181(3): 623-633, 2020 Jun.
Article
in English
| MEDLINE | ID: mdl-32378051
14.
Androgen receptor agonism in advanced oestrogen receptor-positive breast cancer.
Lancet Oncol
; 25(3): 269-270, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38342112
15.
Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study.
Pharmacogenet Genomics
; 29(2): 31-38, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30531377
16.
Adaptive Randomization of Neratinib in Early Breast Cancer.
N Engl J Med
; 375(1): 11-22, 2016 Jul 07.
Article
in English
| MEDLINE | ID: mdl-27406346
17.
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.
N Engl J Med
; 375(1): 23-34, 2016 Jul 07.
Article
in English
| MEDLINE | ID: mdl-27406347
18.
Patient-provider communications about pharmacogenomic results increase patient recall of medication changes.
Pharmacogenomics J
; 19(6): 528-537, 2019 12.
Article
in English
| MEDLINE | ID: mdl-30713337
19.
Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.
Cancer
; 124(14): 3052-3065, 2018 07 15.
Article
in English
| MEDLINE | ID: mdl-29742281
20.
First international TNBC conference meeting report.
Breast Cancer Res Treat
; 169(3): 407-412, 2018 Jun.
Article
in English
| MEDLINE | ID: mdl-29417299